Roland Derwand

Statistics

Publications

Citations

867

H-Index

Active since

2000

Affiliations

Ludwig-Maximilians-Universität München(Current)

Alexion (Germany)

Monroe University

Heinrich Heine University Düsseldorf

Roland Derwand is an author at Ludwig-Maximilians-Universität München specializing in pharmacology, antiviral therapy, and hydroxychloroquine treatment.

Publications per year

2000–2020

Publications

Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?

Roland Derwand, Martin Scholz · Medical Hypotheses · 2020 · 170 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Sphingosine Kinase Modulates Microvascular Tone and Myogenic Responses Through Activation of RhoA/Rho Kinase

Steffen-Sebastian Bolz, Lukas Vogel, Daniel Sollinger et al. · Circulation · 2003 · 143 citations · Full text

Life Sciences, Molecular Biology, Physiology +17

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Paulus Kirchhof, G. Breithardt, E Aliot et al. · EP Europace · 2013 · 140 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Nitric Oxide-Induced Decrease in Calcium Sensitivity of Resistance Arteries Is Attributable to Activation of the Myosin Light Chain Phosphatase and Antagonized by the RhoA/Rho Kinase Pathway

Steffen‐Sebastian Bolz, Lukas Vogel, Daniel Sollinger et al. · Circulation · 2003 · 130 citations

Life Sciences, Pharmacology, Physiology +17

COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

Roland Derwand, Martin Scholz, Vladimir Zelenko · International Journal of Antimicrobial Agents · 2020 · 111 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

1–5 of 10